References
[1] Cho, I., Blaser, M. The human microbiome: at the interface of health and disease. Nat Rev Genet  13,  260–270 (2012).
[2] Kuczynski, J., Lauber, C., Walters, W. et al.  Experimental and analytical tools for studying the human microbiome. Nat Rev Genet  13,  47–58 (2012).
[3] Heinonen, S., Jartti, T., Garcia, C., Oliva, S., Smitherman, C., Anguiano, E., de Steenhuijsen Piters, W. A., Vuorinen, T., Ruuskanen, O., Dimo, B., Suarez, N. M., Pascual, V., Ramilo, O., & Mejias, A. (2016). Rhinovirus Detection in Symptomatic and Asymptomatic Children: Value of Host Transcriptome Analysis. American journal of respiratory and critical care medicine193 (7), 772–782.
[4] Jartti, T., Liimatainen, U., Xepapadaki, P., Vahlberg, T., Bachert, C., Finotto, S., Kowalski, M. L., Sobanska, A., Lukkarinen, H., Pasioti, M., Vuorinen, T., Zhang, N., Zimmermann, T., & Papadopoulos, N. G. (2021). Clinical correlates of rhinovirus infection in preschool asthma. Allergy76 (1), 247–254.
[5] Freer, G., Maggi, F., Pifferi, M., Di Cicco, M. E., Peroni, D. G., & Pistello, M. (2018). The Virome and Its Major Component, Anellovirus, a Convoluted System Molding Human Immune Defenses and Possibly Affecting the Development of Asthma and Respiratory Diseases in Childhood. Frontiers in microbiology9 , 686.
[6] Adiliaghdam, F., Jeffrey, K.L. Illuminating the human virome in health and disease. Genome Med  12,  66 (2020).
[7] Rosenthal, L. A., Avila, P. C., Heymann, P. W., Martin, R. J., Miller, E. K., Papadopoulos, N. G., Peebles, R. S., & Gern, J. E. (2010). Viral respiratory tract infections and asthma: The course ahead. Journal of Allergy and Clinical Immunology125 (6), 1212-1217.
[8] Jartti, T., Smits, H. H., Bønnelykke, K., Bircan, O., Elenius, V., Konradsen, J. R., Maggina, P., Makrinioti, H., Stokholm, J., Hedlin, G., Papadopoulos, N., Ruszczynski, M., Ryczaj, K., Schaub, B., Schwarze, J., Skevaki, C., Stenberg-Hammar, K., Feleszko, W., & EAACI Task Force on Clinical Practice Recommendations on Preschool Wheeze (2019). Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments. Allergy74 (1), 40–52.
[9] Duerkop, B. A., & Hooper, L. V. (2013). Resident viruses and their interactions with the immune system. Nature immunology14 (7), 654–659.
[10] Georgountzou, A., & Papadopoulos, N. G. (2017). Postnatal Innate Immune Development: From Birth to Adulthood. Frontiers in immunology8 , 957.
[11] Koonin, E. V., Dolja, V. V., & Krupovic, M. (2021). The healthy human virome: from virus-host symbiosis to disease. Current opinion in virology47 , 86–94.
[12] Barr, J. J., Auro, R., Furlan, M., Whiteson, K. L., Erb, M. L., Pogliano, J., Stotland, A., Wolkowicz, R., Cutting, A. S., Doran, K. S., Salamon, P., Youle, M., & Rohwer, F. (2013). Bacteriophage adhering to mucus provide a non-host-derived immunity. Proceedings of the National Academy of Sciences of the United States of America110 (26), 10771–10776.
[13] Megremis, S., Constantinides, B., Xepapadaki, P., Bachert, C., Neurath-Finotto, S., Jartti, T., Kowalski, M.L., Sotiropoulos, A., Tapinos, A., Vuorinen, T., Andreakos, E., Robertson, D. & Papadopoulos, N.G. (2020). Bacteriophage deficiency characterizes respiratory virome dysbiosis in childhood asthma. BioRxiv .
[14] Maurer, D. J., Liu, C., Xepapadaki, P., Stanic, B., Bachert, C., Finotto, S., Gao, Y. D., Graser, A., Jartti, T., Kistler, W., Kowalski, M., Lukkarinen, H., Pasioti, M., Tan, G., Villiger, M., Zhang, L., Zhang, N., Akdis, M., Papadopoulos, N. G., & Akdis, C. A. (2021). Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers. Allergy , 10.1111/all.15105. Advance online publication.
[15] Stekhoven, D.J., Bühlmann, P. (2012) MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics, Volume 28, Issue 1, Pages 112–118.
[16] Charrad, M., Ghazzali, N., Boiteau, V., & Niknafs, A. (2014). NbClust: An R Package for Determining the Relevant Number of Clusters in a Data Set. Journal of Statistical Software, 61(6), 1–36.
[17] Budden, K. F., Shukla, S. D., Rehman, S. F., Bowerman, K. L., Keely, S., Hugenholtz, P., … & Hansbro, P. M. (2019). Functional effects of the microbiota in chronic respiratory disease. The Lancet Respiratory Medicine, 7(10), 907-920.
[18] Tzani-Tzanopoulou, P., Skliros, D., Megremis, S., Xepapadaki, P., Andreakos, E., Chanishvili, N., … & Papadopoulos, N. G. (2021). Interactions of Bacteriophages and Bacteria at the Airway Mucosa: New Insights Into the Pathophysiology of Asthma. Frontiers in Allergy1 , 617240.
[19] Seo, S. U., & Kweon, M. N. (2019). Virome–host interactions in intestinal health and disease. Current Opinion in Virology37 , 63-71.
[20] Honda, K., & Littman, D. R. (2016). The microbiota in adaptive immune homeostasis and disease. Nature535 (7610), 75-84.
[21] Ahmad‐Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002). Bacterial CpG‐DNA and lipopolysaccharides activate Toll‐like receptors at distinct cellular compartments. European journal of immunology32 (7), 1958-1968.
[22] Hartmann, G., & Krieg, A. M. (1999). CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene therapy6 (5), 893-903.
[23] Krug, J., Kiefer, A., Koelle, J., Vuorinen, T., Xepapadaki, P., Stanic, B., … & Finotto, S. (2021). TLR7/8 regulates type I and type III interferon signalling in rhinovirus 1b-induced allergic asthma. European Respiratory Journal57 (5).
[24] Bergauer, A., Sopel, N., Kroß, B., Vuorinen, T., Xepapadaki, P., Weiss, S. T., … & Finotto, S. (2017). IFN-α/IFN-λ responses to respiratory viruses in paediatric asthma. European Respiratory Journal49 (2).
[25] Papadopoulos, N. G., Stanciu, L. A., Papi, A., Holgate, S. T., & Johnston, S. L. (2002). A defective type 1 response to rhinovirus in atopic asthma. Thorax57 (4), 328-332.
[26] Contoli, M., Message, S. D., Laza-Stanca, V., Edwards, M. R., Wark, P. A., Bartlett, N. W., … & Johnston, S. L. (2006). Role of deficient type III interferon-λ production in asthma exacerbations. Nature medicine12 (9), 1023-1026.
[27] Xatzipsalti, M., Psarros, F., Konstantinou, G., Gaga, M., Gourgiotis, D., Saxoni‐Papageorgiou, P., & Papadopoulos, N. G. (2008). Modulation of the epithelial inflammatory response to rhinovirus in an atopic environment. Clinical & Experimental Allergy38 (3), 466-472.
[28] Hemann, E. A., Gale Jr, M., & Savan, R. (2017). Interferon lambda genetics and biology in regulation of viral control. Frontiers in immunology8 , 1707.
[29] Yamaya, M., & Sasaki, H. (2004). Rhinovirus and airway allergy. Allergology International53 (2), 37-45.
[30] Bergauer, A., Sopel, N., Kroß, B., Vuorinen, T., Xepapadaki, P., Weiss, S. T., … & Finotto, S. (2017). Rhinovirus species/genotypes and interferon-λ: subtypes, receptor and polymorphisms–missing pieces of the puzzle of childhood asthma?. European Respiratory Journal49 (3).
[31] Li, Y., Fu, X., Ma, J., Zhang, J., Hu, Y., Dong, W., … & Zhang, C. (2019). Altered respiratory virome and serum cytokine profile associated with recurrent respiratory tract infections in children. Nature communications10 (1), 1-12.
[32] Roche, A. M., Richard, A. L., Rahkola, J. T., Janoff, E. N., & Weiser, J. N. (2015). Antibody blocks acquisition of bacterial colonization through agglutination. Mucosal immunology8 (1), 176-185.
[33] Arze, C. A., Springer, S., Dudas, G., Patel, S., Bhattacharyya, A., Swaminathan, H., … & Yozwiak, N. L. (2021). Global genome analysis reveals a vast and dynamic anellovirus landscape within the human virome. Cell Host & Microbe29 (8), 1305-1315.
[34] Levy, M., Kolodziejczyk, A. A., Thaiss, C. A., & Elinav, E. (2017). Dysbiosis and the immune system. Nature Reviews Immunology17 (4), 219-232.
[35] Goggin, R. K., Bennett, C. A., Bialasiewicz, S., Vediappan, R. S., Vreugde, S., Wormald, P. J., & Psaltis, A. J. (2019). The presence of virus significantly associates with chronic rhinosinusitis disease severity. Allergy, 74(8), 1569–1572.
[36] Lukkarinen, H., Söderlund-Venermo, M., Vuorinen, T., Allander, T., Hedman, K., Simell, O., Ruuskanen, O., & Jartti, T. (2014). Human bocavirus 1 may suppress rhinovirus-associated immune response in wheezing children. The Journal of allergy and clinical immunology133 (1), 256–8.e84.
[37] Galani, I. E., Triantafyllia, V., Eleminiadou, E. E., Koltsida, O., Stavropoulos, A., Manioudaki, M., Thanos, D., Doyle, S. E., Kotenko, S. V., Thanopoulou, K., & Andreakos, E. (2017). Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness. Immunity, 46(5), 875–890.e6.
[38] Andreakos, E., Zanoni, I., & Galani, I. E. (2019). Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control. Current opinion in immunology, 56, 67–75.
[39] Koltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Ubel, C., Kotenko, S. V., Sideras, P., Lehr, H. A., Tepe, M., Klucher, K. M., Doyle, S. E., Neurath, M. F., Finotto, S., & Andreakos, E. (2011). IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO molecular medicine, 3(6), 348–361.